Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Artelo Biosciences, Inc. (ARTL) had Free Cash Flow per Share of $-2.59 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$10.11M |
|
$-10.11M |
|
$0.28M |
|
$-9.83M |
|
$-10.11M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
3.22M |
|
3.22M |
|
$-3.05 |
|
$-3.05 |
|
| Balance Sheet Financials | |
$2.56M |
|
-- |
|
$2.14M |
|
$4.70M |
|
$1.77M |
|
-- |
|
$0.07M |
|
$1.84M |
|
$2.86M |
|
$0.82M |
|
$2.86M |
|
3.28M |
|
| Cash Flow Statement Financials | |
$-8.35M |
|
$7.77M |
|
$0.11M |
|
$2.81M |
|
$2.34M |
|
$-0.48M |
|
$0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-343.93% |
|
-1201.22% |
|
-209.15% |
|
-343.93% |
|
$0.87 |
|
|
Free Cash Flow per Share |
$-2.59 |
$-2.59 |
|